Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018)
Jazz Pharmaceuticals' (JAZZ) quarterly Restructuring Costs came in at $44.0 million in Q2 2018, up 307.41% quarter-over-quarter from $10.8 million in Q3 2016.
Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018) Analysis & Trends
Jazz Pharmaceuticals' Restructuring Costs history runs 6 years deep, the most recent figure standing at $44.0 million for Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.81 Bn | 13.96 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 44.00 Mn |
| Sep 30, 2016 | 10.80 Mn |
| Jun 30, 2016 | 2.20 Mn |
| Sep 30, 2014 | 700,000.00 |
| Jun 30, 2014 | 4.40 Mn |
| Mar 31, 2014 | 17.10 Mn |
| Jun 30, 2013 | 400,000.00 |
| Jun 30, 2012 | 8.90 Mn |
| Mar 31, 2012 | 3.50 Mn |
| Sep 30, 2011 | 6.00 Mn |